Alexandria Capital’s Avanos Medical AVNS Stock Holding History

Alexandria Capital’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-31	Closed	-$1K	–	257
2017 Q3	$1K	Hold	31	–	–	﹤0.01%	524
2017 Q2	$1K	Hold	31	–	–	﹤0.01%	579
2017 Q1	$1K	Hold	31	–	–	﹤0.01%	576
2016 Q4	$1K	Hold	31	–	–	﹤0.01%	556
2016 Q3	$1K	Hold	31	–	–	﹤0.01%	567
2016 Q2	$1K	Hold	31	–	–	﹤0.01%	564
2016 Q1	$1K	Hold	31	–	–	﹤0.01%	570
2015 Q4	$1K	Hold	31	–	–	﹤0.01%	615
2015 Q3	$1K	Sell	31 -232	-88%	-$8.09K	﹤0.01%	560
2015 Q2	$11K	Hold	263	–	–	﹤0.01%	405
2015 Q1	$13K	Hold	263	–	–	﹤0.01%	356
2014 Q4	$12K	Buy	+263	New	+$10.3K	﹤0.01%	338

Other funds holding AVNS

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return